405
Participants
Start Date
October 6, 2021
Primary Completion Date
November 28, 2023
Study Completion Date
January 18, 2031
Imatinib
Comes in 100 mg and 400 mg tablets and taken orally
Nilotinib
Comes in 150 mg and 200 mg capsules and taken orally
Bosutinib
Comes in 100 mg and 400 mg tablets and taken orally
Dasatinib
Comes in 20 mg, 50 mg, 70 mg and 100 mg tablets and taken orally
Asciminib
Comes in 40 mg tablets and taken orally
Novartis Investigative Site, Brussels
Novartis Investigative Site, Port Macquarie
Novartis Investigative Site, Kingswood
Novartis Investigative Site, Leuven
Novartis Investigative Site, Linz
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Southport
Novartis Investigative Site, Adelaide
Novartis Investigative Site, Kecskemét
Novartis Investigative Site, Bellinzona
Novartis Investigative Site, Kaposvár
Novartis Investigative Site, Aarhus N
Novartis Investigative Site, Varna
Novartis Investigative Site, George Town
Novartis Investigative Site, Uijeongbu-si
Novartis Investigative Site, Berlin
Novartis Investigative Site, Granada
Novartis Investigative Site, Milan
Novartis Investigative Site, Lübeck
Novartis Investigative Site, Kuantan
Wake Forest University Baptist Medical Center, Winston-Salem
Novartis Investigative Site, Madrid
Novartis Investigative Site, El Palmar
Novartis Investigative Site, Pamplona
Florida Cancer Specialists Pan, Tallahassee
Novartis Investigative Site, Bordeaux
Florida Cancer Specialists, Fort Myers
Novartis Investigative Site, Verona
Chattanooga Onc And Hem Assoc PC, Chattanooga
Novartis Investigative Site, Bologna
Novartis Investigative Site, Taichung
University of Kentucky, Lexington
Novartis Investigative Site, Reggio Emilia
Novartis Investigative Site, Nantes
Novartis Investigative Site, Subang Jaya
Novartis Investigative Site, Aachen
Avera Cancer, Sioux Falls
Novartis Investigative Site, Frankfurt am Main
Novartis Investigative Site, Kuala Selangor
Novartis Investigative Site, Mannheim
Novartis Investigative Site, Lyon
Texas Oncology-Baylor USO, Dallas
Texas Oncology, Dallas
Texas Oncology, Dallas
Novartis Investigative Site, Paris
Rocky Mountain Cancer Centers, Denver
Oregon Health Sciences University, Portland
Williamette Cancer Center, Eugene
Novartis Investigative Site, Beijing
Novartis Investigative Site, Beijing
Novartis Investigative Site, Singapore
Novartis Investigative Site, Singapore
Novartis Investigative Site, Nanjing
Novartis Investigative Site, Suzhou
Novartis Investigative Site, Tianjin
Novartis Investigative Site, Hangzhou
Novartis Investigative Site, Wenzhou
Novartis Investigative Site, Wuhan
Novartis Investigative Site, Zhengzhou
Novartis Investigative Site, Guangzhou
Novartis Investigative Site, Shenzhen
Novartis Investigative Site, Chengdu
Novartis Investigative Site, Xian
Novartis Investigative Site, Lanzhou
Novartis Investigative Site, Petah Tikva
Novartis Investigative Site, Ramat Gan
Novartis Investigative Site, Tel Aviv
Uni of Massachusetts Medical Center, Worcester
Novartis Investigative Site, Calgary
Novartis Investigative Site, Hamilton
Novartis Investigative Site, Ottawa
Novartis Investigative Site, Toronto
Novartis Investigative Site, Hradec Králové
Novartis Investigative Site, Ostrava
Novartis Investigative Site, Brno Bohunice
Novartis Investigative Site, Copenhagen
Novartis Investigative Site, Helsinki
Novartis Investigative Site, Jena
Novartis Investigative Site, Delhi
Novartis Investigative Site, Roma
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Toyoake
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Fukushima
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Kobe
Novartis Investigative Site, Kurashiki
Novartis Investigative Site, Ōsaka-sayama
Novartis Investigative Site, Suita
Novartis Investigative Site, Shimotsuke
Novartis Investigative Site, Chūō
Novartis Investigative Site, Akita
Novartis Investigative Site, Osaka
Novartis Investigative Site, Yamagata
Novartis Investigative Site, Amsterdam
Novartis Investigative Site, Bergen
Novartis Investigative Site, Oslo
Novartis Investigative Site, Porto
Novartis Investigative Site, Vila Nova de Gaia
Novartis Investigative Site, Košice
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Gothenburg
Novartis Investigative Site, Lund
Novartis Investigative Site, Stockholm
Novartis Investigative Site, London
Novartis Investigative Site, Nottingham
Novartis Investigative Site, Oxford
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY